BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Paradigm Spine, LLC Announces Strategic Promotions and Hiring of Key Personnel to Ensure Long-Term Growth and Success


3/15/2012 9:02:21 AM

NEW YORK, March 14, 2012 /PRNewswire/ -- Paradigm Spine, LLC, a leading provider of spinal implant technologies, announces the promotion and addition of key strategic personnel to strengthen operations and further position the Company for long-term growth.

Guntmar Eisen has been promoted to the position of President and Chief Operating Officer ("COO"). As co-founder of Paradigm Spine, LLC, he has extensive operating experience in the global spine industry.

Prior to founding Paradigm, he held positions of increasing responsibility in product development and commercial operations with Aesculap and Spine Solutions. He led several successful new product introductions, including the worldwide launch of PRODISC®. Guntmar is a graduate of HFU Hochschule Furtwangen University and is well prepared to lead the next phase of the company's development, focusing on the introduction of the coflex® device to the U.S. market upon regulatory approval.

Steven Amelio has joined as the Company's new Chief Financial Officer. Steven will lead all financial administration, business planning and budgeting functions, and will partner with the Executive Management Team on all operating and strategic initiatives.

Steven has 24 years of experience in the medical device industry with U.S. Surgical Corporation, Tyco Healthcare Group, L.P., and Covidien, PLC. He has held positions of increasing responsibility throughout his career, including Division Chief Financial Officer. Steven has been involved in all aspects of acquisitions, divestitures, and was instrumental in the purchase of technologies in minimally invasive, electro-surgical, orthopedic and bio-surgery segments. Most recently, Steven was the Chief Financial Officer for DeVilbiss Healthcare, LLC. Steve has an MBA in Finance and a BBA in Accounting from Iona College in New York.

Mark J. Suseck has joined as the Company's new Vice President of Marketing. Mark will be responsible for providing executive leadership and management of all U.S. marketing activities, including product management, communications, market research, new product launch initiatives and sales force and surgeon training activities.

Mark is a global marketing leader with demonstrated results in specialty devices and biopharmaceuticals. Mark has successfully led marketing efforts for Johnson & Johnson, sanofi-aventis and GE Healthcare in the areas of minimally invasive surgery, central nervous system disorders, oncology, diabetes, and cardiology. Mark earned his BA in economics from Rutgers College, with minors in Philosophy and Education. He has also completed the Executive Management Program at the University of Michigan. Mark is certified in Six Sigma Process Excellence and Digital Marketing. He has been a faculty presenter at the J&J Marketing Excellence Program, and is a former member and program director for the Conference Board Council of Marketing Executives.

About Paradigm Spine, LLC -

Paradigm Spine is a privately held company focused on the design, development and marketing of solutions for the treatment of spinal conditions and diseases. The company's signature product is the coflex® device, which is currently used in over 40 countries around the world. It is an investigational device under FDA review in the United States. When available for use, the coflex® device will be the first and only non-fusion, minimally invasive, motion-preserving device that stabilizes spinal stenosis patients after decompression due to its unique interlaminar design. For additional information visit www.paradigmspine.com.

SOURCE Paradigm Spine, LLC


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->